Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

The antilipidemic drug, probucol (PB), has demonstrated potential applications in Type 2 diabetes (T2D) through its protective effects on pancreatic β-cells. PB has poor solubility and bioavailability, and despite attempts to improve its oral delivery, none has shown dramatic improvements in absorpt...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooranian, Armin, Raj Wagle, Susbin, Kovacevic, Bozica, Takechi, Ryu, Mamo, John, Lam, Virginie, Watts, Gerald F., Mikov, Momir, Golocorbin-Kon, Svetlana, Stojanovic, Goran, Al-Sallami, Hesham, Al-Salami, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952395/
https://www.ncbi.nlm.nih.gov/pubmed/31919411
http://dx.doi.org/10.1038/s41598-019-53999-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952395/
https://www.ncbi.nlm.nih.gov/pubmed/31919411
http://dx.doi.org/10.1038/s41598-019-53999-1

Ejemplares similares